Complete Blood Cell Count-Based Ratios Identify Total Joint Arthroplasty Patients Likely to Benefit from Perioperative Dexamethasone
Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.
Authors
- Ian A. Jones (ORCID: https://orcid.org/0000-0002-6051-4762)
- Cory K. Mayfield (ORCID: https://orcid.org/0000-0001-5268-3817)
- Julian Wier (ORCID: https://orcid.org/0000-0001-7142-604X)
- Nicholas J Kassebaum (ORCID: https://orcid.org/0000-0002-4299-9348)
- Jay R. Lieberman (ORCID: https://orcid.org/0000-0002-1374-8929)
- Ryan Palmer (ORCID: https://orcid.org/0000-0001-5201-7371)
- Nathanael D. Heckmann (ORCID: https://orcid.org/0000-0003-1293-1702)
Institutions
- University of Southern California (US)
- University of Washington (US)
Publication Details
- Journal
- Journal of Bone and Joint Surgery
- Published
- 2024-11-20
- DOI
- https://doi.org/10.2106/jbjs.24.00184
- Citations
- 2
- Primary Topic
- Total Knee Arthroplasty Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 1.15